Status:
UNKNOWN
Cerebral Morbidity After Radiation Therapy for Brain Tumors
Lead Sponsor:
University of Aarhus
Conditions:
Brain Tumor
Cognitive Impairment
Eligibility:
All Genders
18-100 years
Brief Summary
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of ...
Detailed Description
RT to brain tumours causes cognitive dysfunction. The extent of RT induced changes in cognitive function and radio-sensitivity of the brain is unknown. RT with protons instead of photons spares the he...
Eligibility Criteria
Inclusion
- 18 years or older and Danish speaking.
- Performance status WHO 0-2
- Capable of cooperating on testing
- Tumor histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligidendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas
Exclusion
- Glioblastoma
- Performance status 3-4
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04292353
Start Date
July 1 2016
End Date
September 30 2024
Last Update
May 5 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospital
Copenhagen, Region H, Denmark, 2100
2
Department of Oncology
Aarhus, Region Midt, Denmark, 8000
3
Aalborg University Hospital
Aalborg, Region Nord, Denmark, 9000
4
Odense University Hospital
Odense, Region Syd, Denmark, 5000